Catalyst Wire Dossier Catalyst Wire Dossier

WVE-006

· Wave Life Sciences Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WVE-006, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1) [Phase 1]

See pricing